An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease
Open Access
- 22 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-13
- https://doi.org/10.1038/s41467-020-20750-8
Abstract
Elevated plasma cholesterol and type 2 diabetes (T2D) are associated with coronary artery disease (CAD). Individuals treated with cholesterol-lowering statins have increased T2D risk, while individuals with hypercholesterolemia have reduced T2D risk. We explore the relationship between lipid and glucose control by constructing network models from the STARNET study with sequencing data from seven cardiometabolic tissues obtained from CAD patients during coronary artery by-pass grafting surgery. By integrating gene expression, genotype, metabolomic, and clinical data, we identify a glucose and lipid determining (GLD) regulatory network showing inverse relationships with lipid and glucose traits. Master regulators of the GLD network also impact lipid and glucose levels in inverse directions. Experimental inhibition of one of the GLD network master regulators, lanosterol synthase (LSS), in mice confirms the inverse relationships to glucose and lipid levels as predicted by our model and provides mechanistic insights.Keywords
This publication has 73 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistanceNature Genetics, 2012
- Systems analysis of eleven rodent disease models reveals an inflammatome signature and key driversMolecular Systems Biology, 2012
- GCTA: A Tool for Genome-wide Complex Trait AnalysisAmerican Journal of Human Genetics, 2011
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networksNature Genetics, 2008
- Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin ResistanceOnline Journal of Public Health Informatics, 2008
- An integrative genomics approach to infer causal associations between gene expression and diseaseNature Genetics, 2005
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Proceedings of the National Academy of Sciences of the United States of America, 2005
- Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterolCell Metabolism, 2005